Association between fibrocystic breast disease and polycystic ovarian syndrome phenotypes: A cross-sectional study

سال انتشار: 1404
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 56

فایل این مقاله در 12 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJRM-23-10_002

تاریخ نمایه سازی: 15 آذر 1404

چکیده مقاله:

Background: Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders among women of reproductive age and is associated with various hormonal and metabolic complications. Objective: This study aimed to investigate the association between PCOS and fibrocystic breast disease (FBD) and to analyze the prevalence of FBD across different PCOS phenotypes. Materials and Methods: In this cross-sectional study, data of ۱۲۰ women diagnosed with either FBD or PCOS who referred to Kamali hospital, affiliated with Alborz University of Medical Sciences, Karaj, Iran from March ۲۰۲۴-March ۲۰۲۵ were extracted from their medical records. Participants were divided into ۲ groups: PCOS (n = ۶۵) and control (n = ۵۵). The prevalence of FBD was compared between the PCOS and control groups. Furthermore, the distribution of FBD across different PCOS phenotypes (A-D) based on the Rotterdam criteria was analyzed. Hormonal profiles (luteinizing hormone, follicle-stimulating hormone, testosterone, estrogen, progesterone, anti-Müllerian hormone) and metabolic parameters were also compared between the groups. Results: The prevalence of FBD was significantly higher in the PCOS group compared to the control group (۵۸.۳% vs. ۳۰%; p = ۰.۰۰۳). The highest prevalence of FBD was observed in phenotype A (۸۱.۸%). Logistic regression analysis indicated that having PCOS increased the risk of developing FBD by more than ۳ times (odds ratio = ۳.۱۲; ۹۵% CI: ۱.۵۱-۶.۴۵). Levels of luteinizing hormone, follicle-stimulating hormone, and testosterone were significantly elevated in the PCOS group. Conclusion: The findings of this study indicate that PCOS, particularly in phenotypes associated with hyperandrogenism and anovulation, is significantly associated with an increased prevalence of FBD. These results underscore the importance of breast health screening and monitoring in women with PCOS.

نویسندگان

Ramesh Baradaran Bagheri

Department of Obstetrics and Gynecology, Alzahra Hospital, Faculty of Medicine, Alborz University of Medical Sciences, Karaj, Iran.

Leila Hajimaghsoudi

Department of Surgery, Faculty of Medicine, Alborz University of Medical Sciences, Karaj, Iran.

Seyedeh Sanaz Mirrahimi

Department of Operation Room, Faculty of Paramedicine, Alborz University of Medical Sciences, Karaj, Iran.

Abolfazl Mahmoudnezhad Atash beyg

Department of Pediatrics, Imam Ali Hospital, Alborz University of Medical Sciences, Karaj, Iran.

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Kunicki M, Smolarczyk R. Polycystic ovary syndrome and fibrocystic breast ...
  • Karkera S, Agard E, Sankova L. The clinical manifestations of ...
  • Baradaran Bagheri R, Chavoshinezhad N, Barghi B, Soleymaniinallou M, Shokoohi ...
  • Baradaran Bagheri R, Khaki AA. [Effects of carvacrol on hormonal ...
  • Dewailly D. Diagnostic criteria for PCOS: Is there a need ...
  • Jain S, Jain M, Shukla RC. Correlation of clinical, hormonal, ...
  • Mallick S, Benson R, Julka PK. Breast cancer prevention with ...
  • Levin ER, Hammes SR. Estrogens and progestins. In: Brunton LL, ...
  • Bland KI, Copeland EM, Klimberg VS, Gradishar WJ. Bland and ...
  • Davey MG, Hynes SO, Kerin MJ, Miller N, Lowery AJ. ...
  • Baradaran Bagheri R, Salami SS, Mohammadzadeh Boukani L, Khaki AA. ...
  • Harada M. Pathophysiology of polycystic ovary syndrome revisited: Current understanding ...
  • Wang R, Mol BWJ. The Rotterdam criteria for polycystic ovary ...
  • Pratama G, Wiweko B, Asmarinah, Widyahening IS, Andraini T, Bayuaji ...
  • Mohammed ZI, Qasim MT. Correlation of AMH and LH levels ...
  • Mohammadi PM, Bagheri RB, Far FS, Ansari M, Mirzaei M, ...
  • Eftekhar M, Bagheri RB, Neghab N, Hosseinisadat R. Evaluation of ...
  • Dilbaz B, Özkaya E, Cinar M, Cakir E, Dilbaz S. ...
  • Barry JA, Azizia MM, Hardiman PJ. Risk of endometrial, ovarian ...
  • Dang B, Clewis M, Miles B, Nguyen Q. The effect ...
  • Harris H, Titus L, Cramer D, Terry K. Long and ...
  • Kohnepoushi P, Dehghanbanadaki H, Mohammadzedeh P, Nikouei M, Moradi Y. ...
  • Harris HR, Cushing-Haugen KL, Webb PM, Nagle CM, Jordan SJ, ...
  • De Leo V, Musacchio M, Cappelli V, Massaro M, Morgante ...
  • Kunicki M, Smolarczyk R. Polycystic ovary syndrome and fibrocystic breast ...
  • Karkera S, Agard E, Sankova L. The clinical manifestations of ...
  • Baradaran Bagheri R, Chavoshinezhad N, Barghi B, Soleymaniinallou M, Shokoohi ...
  • Baradaran Bagheri R, Khaki AA. [Effects of carvacrol on hormonal ...
  • Dewailly D. Diagnostic criteria for PCOS: Is there a need ...
  • Jain S, Jain M, Shukla RC. Correlation of clinical, hormonal, ...
  • Mallick S, Benson R, Julka PK. Breast cancer prevention with ...
  • Levin ER, Hammes SR. Estrogens and progestins. In: Brunton LL, ...
  • Bland KI, Copeland EM, Klimberg VS, Gradishar WJ. Bland and ...
  • Davey MG, Hynes SO, Kerin MJ, Miller N, Lowery AJ. ...
  • Baradaran Bagheri R, Salami SS, Mohammadzadeh Boukani L, Khaki AA. ...
  • Harada M. Pathophysiology of polycystic ovary syndrome revisited: Current understanding ...
  • Wang R, Mol BWJ. The Rotterdam criteria for polycystic ovary ...
  • Pratama G, Wiweko B, Asmarinah, Widyahening IS, Andraini T, Bayuaji ...
  • Mohammed ZI, Qasim MT. Correlation of AMH and LH levels ...
  • Mohammadi PM, Bagheri RB, Far FS, Ansari M, Mirzaei M, ...
  • Eftekhar M, Bagheri RB, Neghab N, Hosseinisadat R. Evaluation of ...
  • Dilbaz B, Özkaya E, Cinar M, Cakir E, Dilbaz S. ...
  • Barry JA, Azizia MM, Hardiman PJ. Risk of endometrial, ovarian ...
  • Dang B, Clewis M, Miles B, Nguyen Q. The effect ...
  • Harris H, Titus L, Cramer D, Terry K. Long and ...
  • Kohnepoushi P, Dehghanbanadaki H, Mohammadzedeh P, Nikouei M, Moradi Y. ...
  • Harris HR, Cushing-Haugen KL, Webb PM, Nagle CM, Jordan SJ, ...
  • De Leo V, Musacchio M, Cappelli V, Massaro M, Morgante ...
  • نمایش کامل مراجع